Japanese Journal of Clinical Immunology
Online ISSN : 1349-7413
Print ISSN : 0911-4300
ISSN-L : 0911-4300
Improved rheumatoid arthritis case with Ge-132 administration evaluated by clinically and immunologically using two-color flow cytometry
Arimori ShigeruYoshida MiyokoIchimura Kaori
Author information
JOURNAL FREE ACCESS

1990 Volume 13 Issue 1 Pages 80-86

Details
Abstract
Ge-132, 1, 500mg per day, was administered to 47 y-o house wife who suffered from rheumatoid arthritis associated with Sjögren's syndrome and microcytic hypochromic anemia since 1983. Her clinical stage of rheumatoid arthritis was Stage II and class was 1. Polyarth-ralgia and joint swelling were getting worse even though she was administered both non-steroidal antiinflammatory drug and small dose of prednisolone. Treatment with Ge-132 brought her in a remission state of rheumatoid arthritis and MCV and MCH as well as Hb were improved within 5 months. Two-color flow cytometry of peripheral lymphocytes demonstrated an increase of lymphocyte, CD3-, CD21+ (B cell), CD3+, CD21- (T cell), CD4-, CD8+ (suppressor T cell), CD4+, CD8- (helper T cell), CD16+, DR- (NK cell) and all of double negative cells such as CD3-, CD21- cell, CD4-, C8- cell, and CD16-, DR-cell, parallel to clinical status.
These data surely indicated that Ge-132 is effective to this patient.
Content from these authors
© The Japan Society for Clinical Immunology
Previous article Next article
feedback
Top